Moreover, the pretreatment of sulforaphane (SFN) in the ischemic stroke model could protect neurovascular and alleviate neurological deficits and BBB disruption via the Nrf2/HO-1 defense pathway (Alfieri et al., 2013; Warpsinski et al., 2020). Here, NFE2L2 is linked to ischemic stroke.